Establishing an inter-Korean biomedical cluster could be one of the methods for two Koreas to cooperate in the health sector, an expert said.The Korean Society of Global Health and the Association of Healthcare for Korean Unification hosted a conference, “Global Health Crisis and the Health Communit
President Moon Jae-in instructed quarantine authorities to shift to a system coping with the Omicron variant during his official visit to Egypt on Thursday.“It has become an established fact that the Omicron variant is a dominant strain in our country, too,” President Moon was quoted as saying by Ch
The U.S. FDA recently approved two JAK inhibitors – AbbVie’s Rinvoq (upadacitinib) and Pfizer’s Cibinqo (abrocitinib) – to treat atopic dermatitis on the condition that JAK inhibitors are given to those who have already received systemic therapy, including biologics.In Korea, the Ministry of Food an
“Until now, there was no way to prevent recurrence of breast cancer in high-risk HER2 early breast cancer patients who completed adjuvant antibody treatment. As there is no treatment to prevent brain metastasis, the market release of Nerlynx (ingredient: neratinib) could satisfy the unmet demand of
Noul, a diagnostic test platform company, said Wednesday it has submitted a registration statement to the Financial Services Commission and entered into the initial public offering (IPO) procedure.The company plans to offer 1.5 million depository receipts at 13,000-17,000 won ($11-$14.2) per share t
A set of unfavorable factors has engulfed biopharmaceutical companies to pull down their stock prices this month, extending last year’s downward trend.The market capitalization of biopharmaceutical stocks, which shrank by 70 trillion won ($58.8 billion) last year, has shed an additional 30 trillion
LG Chem said on Wednesday that the U.S. FDA authorized the company to conduct a phase 1 clinical trial of LG542019, a type-2 diabetes treatment candidate, which aims to reduce insulin resistance.The study will evaluate LC542019’s safety, tolerability, pharmacokinetics, and pharmacodynamics in 98 hea
The government will exempt people who receive hospital treatments within six weeks of injection due to the Covid-19 vaccine's adverse reaction from the vaccine mandate from Monday.Quarantine officials also said they would exclude cases where health authorities have failed to determine causality evid
A research team at Ajou University School of Medicine has discovered that Korea's young adult diabetes population is increasing.According to the university, the prevalence of diabetes has been increasing worldwide, and Korea is also experiencing a surge in the prevalence of diabetes amid population
The government is expected to allow functional health foods to be packaged in small amounts this year.Industry watchers are paying attention to whether JVM, a drug packaging subsidiary of Hanmi Science, will benefit from this and see sales increase in 2022.According to a report by EBEST Investment &
The Korea Health Industry Development Institute (KHIDI) said it has entered a three-way partnership with the Abu Dhabi Department of Health and Abu Dhabi Public Health Center to strengthen cooperation in healthcare, including patient transfers.Under the accord, the three parties will provide educati
Multinational pharmaceutical companies continued to dominate Korea’s new drug market last year by winning nine out of 10 new drugs approvals.According to the new drug data at the Ministry of Food and Drug Safety, the regulator approved 48 new drugs -- 35 synthetic drugs and 13 biological drugs – dev
HLB Life Sciences said it has acquired all rights for an anticancer candidate substance developed by LSK NRDO, a local drug developer.The new anticancer substance features a mechanism that inhibits the proliferation of cancer cells by regulating signals involved in the cell cycle. The cell cycle ref
AstraZeneca’s anti-PD-L1 immunotherapy Imfinzi (ingredient: durvalumab) in combination with the standard chemotherapy lowered the risk of death by 20 percent in the treatment of biliary tract cancer, the company said.The results came from a global phase 3 trial, expanded from a phase 2 study led by
The Korea Exchange said it tentatively decided to delist Sillajen from the tech-heavy Kosdaq market. Following the KRX decision, the Kosdaq market committee will determine whether to delist the biotech firm.On Tuesday, the KRX held a meeting of the corporate review committee and said it would kick S
The government will provide up to 5 million won ($4,200) for students suffering from severe adverse reactions after the Covid-19 vaccination.Students under 18 showing serious side effects within 90 days of injections, albeit without confirmed causality with vaccinations, will be eligible for the med
Fortnova, a subsidiary of immuno-oncology developer Eutilex, has obtained Food and Drug Safety Ministry’s approval as an official institution to analyze clinical test samples.The approval has made Fortnova an accredited organization providing analysis services for human biologic materials needed for
Two researchers at Seoul St. Mary's Hospital released a study result on Tuesday, which stresses the need for people with poor lung function to monitor their health, especially the possibility of diabetes closely.Diabetes mellitus is a systemic inflammatory disease in which high blood sugar persists
SK Bioscience has taken one more step towards commercializing a Korean-made Covid-19 vaccine.The company said it completed recruiting participants in a local phase 3 study of Covid-19 vaccine candidate GBP510.SK Bioscience is leading the race to make a homegrown Covid-19 vaccine among Korean vaccine
HLB Therapeutics said Tuesday that the U.S. Food and Drug Administration had approved the execution of an expanded access program (EAP) for its OKN-007, a treatment candidate for pediatric patients with disseminated intrinsic glioma (DIPG).The company has started administering the first dose of the